These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1396987)

  • 41. A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists.
    Lodge D; Davies SN; Jones MG; Millar J; Manallack DT; Ornstein PL; Verberne AJ; Young N; Beart PM
    Br J Pharmacol; 1988 Nov; 95(3):957-65. PubMed ID: 2905186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice.
    Assi AA
    J Pharm Pharm Sci; 2001; 4(1):42-51. PubMed ID: 11302789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis. IV. Effects of CGP 39551.
    Velísek L; Vachová D; Mares P
    Pharmacol Biochem Behav; 1997 Mar; 56(3):493-8. PubMed ID: 9077588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.
    Yen W; Williamson J; Bertram EH; Kapur J
    Epilepsy Res; 2004 Mar; 59(1):43-50. PubMed ID: 15135166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
    Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
    Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anticonvulsant properties of some calcium antagonists on sound-induced seizures in genetically epilepsy prone rats.
    De Sarro G; De Sarro A; Federico F; Meldrum BS
    Gen Pharmacol; 1990; 21(5):769-78. PubMed ID: 2276595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II. Pharmacological characterization in vivo.
    Urwyler S; Campbell E; Fricker G; Jenner P; Lemaire M; McAllister KH; Neijt HC; Park CK; Perkins M; Rudin M; Sauter A; Smith L; Wiederhold KH; Müller W
    Neuropharmacology; 1996 Jun; 35(6):655-69. PubMed ID: 8887975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of ionotropic glutamate receptor channel blockers on the development of audiogenic seizures in Krushinski-Molodkina rats].
    Lukomskaia NIa; Vataev SI; Zhabko EP; Magazanik LG
    Ross Fiziol Zh Im I M Sechenova; 2012 Apr; 98(4):449-60. PubMed ID: 22834334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The anticonvulsant action of CI-977, a selective kappa-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex.
    Singh L; Vass CA; Hunter JC; Woodruff GN; Hughes J
    Eur J Pharmacol; 1990 Dec; 191(3):477-80. PubMed ID: 1964913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy.
    Rundfeldt C; Wlaź P; Löscher W
    Brain Res; 1994 Aug; 653(1-2):125-30. PubMed ID: 7982045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. APH, an N-methyl-D-aspartate receptor antagonist, blocks the metaphit-induced audiogenic seizures in rats.
    Zivanovic D; Susic V; Stanojlovic O
    J Physiol Paris; 1997 Dec; 91(6):317-23. PubMed ID: 9457665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of competitive and non-competitive NMDA receptor antagonists in spinal cord injury.
    Faden AI; Ellison JA; Noble LJ
    Eur J Pharmacol; 1990 Jan; 175(2):165-74. PubMed ID: 2155794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats.
    Mares P; Mikulecká A
    Epilepsy Behav; 2009 Jan; 14(1):32-9. PubMed ID: 18786655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of audiogenic seizures in DBA/2 mice by two new dipeptide NMDA receptor antagonists.
    Jones AW; Croucher MJ; Meldrum BS; Watkins JC
    Neurosci Lett; 1984 Mar; 45(2):157-61. PubMed ID: 6145126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice.
    Chapman AG; Meldrum BS
    Eur J Pharmacol; 1989 Jul; 166(2):201-11. PubMed ID: 2676564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task.
    Mathis C; Paul SM; Crawley JN
    Psychopharmacology (Berl); 1994 Oct; 116(2):201-6. PubMed ID: 7862949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.